Great West Life Assurance CO Travere Therapeutics, Inc. Transaction History
Great West Life Assurance CO
- $49.6 Billion
- Q1 2024
A detailed history of Great West Life Assurance CO transactions in Travere Therapeutics, Inc. stock. As of the latest transaction made, Great West Life Assurance CO holds 6,902 shares of TVTX stock, worth $67,639. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,902
Previous 6,902
-0.0%
Holding current value
$67,639
Previous $62,000
14.52%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding TVTX
# of Institutions
185Shares Held
91.5MCall Options Held
66.9KPut Options Held
265K-
Black Rock Inc. New York, NY7.8MShares$76.4 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY7.5MShares$73.5 Million0.79% of portfolio
-
Deep Track Capital, LP Greenwich, CT7.37MShares$72.2 Million1.88% of portfolio
-
State Street Corp Boston, MA6.61MShares$64.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.27MShares$61.4 Million0.0% of portfolio
About Travere Therapeutics, Inc.
- Ticker TVTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 64,173,600
- Market Cap $629M
- Description
- Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...